Bitcoin 'Accumulator' Better Fit for Corporates Than Dollar-Cost Averaging Strategy, Research Suggests While investors of all kinds widely prefer DCA, new research shows that since 2023, it has ...

Physical therapists in New York are seeing an uptick in younger male patients with penile and bladder issues.

The U.S. Food and Drug Administration on Thursday approved UroGen Pharma's drug to treat a type of bladder cancer, providing an alternative treatment as opposed to traditional surgical procedures.

The FDA has granted approval to UGN-102 for use in patients with low-grade intermediate-risk non-muscle-invasive bladder cancer.

There are new questions about who — in the rubber industry — is affected by bladder cancer. A former Sumitomo Rubber employee is coming forward and voicing concern about his diagnosis.

Surgeons from Keck Medicine of USC and UCLA Health successfully perform the world's first-in-human bladder transplant, offering new hope for severe bladder dysfunction.

How does peeing ‘just in case’ affect bladder health? To understand why proactive voiding can be harmful, it helps to know how the bladder works.

Elon Musk's frequent use of ketamine during the 2024 campaign caused him to experience bladder problems, according to The New York Times.

Surgeons in Southern California have performed the first human bladder transplant, introducing a new, potentially life-changing procedure for people with debilitating bladder conditions.

RemeGen's China readout bodes well for Pfizer’s own global phase 3 trial that pairs disitamab vedotin with Keytruda in in first-line bladder cancer.

TAR-200 demonstrated a high disease-free survival and bladder preservation rates in BCG-unresponsive, high-risk non-muscle-invasive bladder cancer.

J&J’s ambition in non-muscle invasive bladder cancer will likely tee off a showdown between its TAR-200 and ImmunityBio’s immunotherapy Anktiva.